Your browser doesn't support javascript.
loading
Prolonged Amenorrhea and Low Hip Bone Mineral Density in Women Living With HIV-A Controlled Cross-sectional Study.
King, Elizabeth M; Nesbitt, Ariel; Albert, Arianne Y K; Pick, Neora; Cote, Helene C F; Maan, Evelyn J; Prior, Jerilynn C; Murray, Melanie C M.
Afiliação
  • King EM; Division of Infectious Diseases, Department of Medicine, University of British Columbia (UBC), Vancouver, British Columbia, Canada.
  • Nesbitt A; Division of Infectious Diseases, Department of Medicine, University of British Columbia (UBC), Vancouver, British Columbia, Canada.
  • Albert AYK; Women's Health Research Institute, British Columbia (BC) Women's Hospital, Vancouver, British Columbia, Canada.
  • Pick N; Oak Tree Clinic, BC Women's Hospital, Vancouver, British Columbia, Canada.
  • Cote HCF; Division of Infectious Diseases, Department of Medicine, University of British Columbia (UBC), Vancouver, British Columbia, Canada.
  • Maan EJ; Women's Health Research Institute, British Columbia (BC) Women's Hospital, Vancouver, British Columbia, Canada.
  • Prior JC; Oak Tree Clinic, BC Women's Hospital, Vancouver, British Columbia, Canada.
  • Murray MCM; Women's Health Research Institute, British Columbia (BC) Women's Hospital, Vancouver, British Columbia, Canada.
J Acquir Immune Defic Syndr ; 83(5): 486-495, 2020 04 15.
Article em En | MEDLINE | ID: mdl-31914005
ABSTRACT

BACKGROUND:

Women living with HIV (WLWH) have higher rates of prolonged secondary amenorrhea (no flow for ≥1 year) than HIV-negative women. Both having amenorrhea and being HIV positive are associated with lower areal bone mineral density (BMD). However, their combined BMD effects remain unclear. Therefore, we investigated prolonged amenorrhea and BMD in WLWH and controls.

METHODS:

This cross-sectional study enrolled WLWH and HIV-negative control women aged 19-68 years of similar backgrounds. We assessed BMD (Hologic; as age- and ethnicity-matched Z-scores) in the Children and women AntiRetrovirals and Markers of Aging cohort. Participants were stratified by amenorrhea history defined as past/present lack of menses for ≥1 year at age 45 and younger and not because of surgery, breastfeeding, pregnancy, or hormonal contraception. Hip and spine Z-scores by amenorrhea/no amenorrhea used linear models with multivariable analysis for relationships within WLWH.

RESULTS:

WLWH (N = 129) were similar to controls (N = 129) in age, body mass index, ethnicity, and substance use. Among WLWH, 21% experienced prolonged amenorrhea vs. 9% in controls. WLWH had significantly lower total hip (mean ± SD -0.4 ± 0.9 vs. 0.3 ± 1.1; P < 0.001) and spine (-0.5 ± 1.3 vs. 0.2 ± 1.3; P = 0.001) Z-scores than controls. Amenorrhea was independently associated with hip (P = 0.01) but not spine (P = 0.94) BMD by multivariable linear regression. WLWH with amenorrhea had lower hip Z-scores (-0.8 ± 0.9) than those without (-0.3 ± 0.8; P = 0.01). They also had higher rates of substance use, smoking, opioid therapy, hepatitis C coinfection, and lower CD4 nadir.

CONCLUSIONS:

WLWH had higher rates of prolonged amenorrhea and lower BMD than controls. WLWH with amenorrhea experienced lower hip BMD Z-scores than those without. Prolonged amenorrhea is an added osteoporosis risk in WLWH.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Ósseas Metabólicas / Infecções por HIV / Amenorreia Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Ósseas Metabólicas / Infecções por HIV / Amenorreia Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá